BioNet-Asia Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Bangkok Thailand (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2016
NCT02946190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

BioNet-Asia | Bionet Co., Ltd